Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

Quotes for PEPTONIC Medical AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
88,1
Time (Latest trade)

Board

CEO

  • Erik Sundquist

Chairperson of the Board

  • Anders Blom

Board

  • Anders Norling
  • Anna Stinger
  • Daniel Rudeklint
  • Tarek Schoeb

Videos

Largest Owners

Name Capital % Votes % Date
Maida Vale Capital AB 17,95 17,95 2023-06-28
Vidarstiftelsen 14,46 14,46 2023-06-28
Avanza Pension 5,27 5,27 2023-06-28
Tarek Nabil Shoeb 3,74 3,74 2023-06-28
Stein Jens-Peter 3,74 3,74 2023-06-28
Heli Kurjanen 3,71 3,71 2022-12-31
Nordnet Pensionsförsäkring 3,53 3,53 2023-06-28
Mika Kurjanen 1,93 1,93 2022-12-28
Karl Arne Emanuel Ryberg 1,31 1,31 2023-06-28
Henrik Hahn 1,28 1,28 2023-06-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream